Optimizing PrEP Uptake and Adherence Among Male Sex Workers
Efficacy of a PrEP Uptake & Adherence Intervention Among Male Sex Workers Using a 2-stage Randomization Design
Brown University
500 participants
Nov 3, 2022
INTERVENTIONAL
Conditions
Summary
"PrEPare for Work" is a randomized controlled trial (RCT) whose goal is to test the efficacy of a behavioral intervention (Short Title: PrEPare for Work) in improving PrEP uptake, adherence, and persistence among male sex workers (MSW)
Eligibility
Inclusion Criteria8
- Age: 18 years or older
- Assigned male sex at birth
- Identifies as male at enrollment
- Report having engaged in condomless anal sex with another man in the past 3 months
- Report having exchanged sex for money, drugs, items of value, or a place to stay with another man in the past 3 months
- Report HIV status as negative or unsure
- Not currently on PrEP
- Able to understand and speak English or Spanish
Exclusion Criteria4
- Unable to provide informed consent due to severe mental or physical illness, cognitive impairment, or substance intoxication at the time of interview (will use an adapted version of the Evaluation to Sign Consent Form65 to assess capacity)
- Discovery of active suicidal ideation or major mental illness (e.g. untreated psychosis or mania) at the time of interview (these patients will be referred immediately for treatment)
- Laboratory or clinical findings that would preclude PrEP initiation (e.g. Chronic Hepatitis B Virus infection, decreased creatinine clearance)
- Participated in the pilot RCT and initiated PrEP during study participation
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Intervention participants will receive a trained SBCM to motivate, support, and assist in linkage to PrEP prescribers to help facilitate obtaining PrEP medication to initiate treatment.
Intervention participants will receive 1-on-1 adherence counseling and personalized daily text messaging reminders to increase PrEP adherence. Intervention participants will undergo three adherence intervention sessions (once per week for 3 weeks) with interventionist.
Locations(5)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05736614